Vyome Holdings, Inc. HIND 深 滬
已收盤 02-06 16:00:00 美东时间
2.74
+0.440
+19.13%
華盛通- 最 高2.9299
- 今 開2.28
- 成交量 48.37万股
- 最 低 2.28
- 昨 收 2.30
- 總市值 1546.59万
- 52周最高 16.00
- 市盈率 靜 --
- 換手率 8.57%
- 52周最低 0.30
- 委 比 49.25%
- 總股本 564.45万
- 歷史最高 22.40
- 量 比 0.72
- 振 幅 28.26%
- 歷史最低 0.018
- 每 手 1
- 風險率 2.63%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers ENvue Medical (NASDAQ:FEED) stock moved upwards by 19.0% to $1.25 duri...
01-28 20:05
Independent Analysis Estimates Vyome Holdings' VT-1953 At ~$1B Post-Phase 3 Value, And ~$600M Annual Peak Sales Potential
Third-party analysis estimates the total addressable U.S. market to be approximately USD 2.2 billionModeled peak annual U.S. sales approaching USD 600 million for VT-1953Independent valuation analysis estimates
01-27 21:07
Vyome Holdings' Subsidiary LiveChain Enters Binding LOI To Acquire Humanyze Convertible Note In Equity Exchange with Remus Capital
Entry into a Material Definitive Agreement Letter of Intent with LICH and Remus: On December 17, 2025, Vyome Holdings, Inc. (the "Company") entered into a binding letter of intent (the "LOI") among, the
2025-12-24 05:17
Vyome's VT-1953 Announces Phase 2 Efficacy In Malignant Fungating Wounds, Paving Path To Pivotal Trial
VT-1953 treatment over 14 days resulted in highly statistically significant improvements in bad smell or malodor associated with malignant fungating wound (primary endpoint) (P = 0.002).Patient-reported impact of bad
2025-12-08 21:10
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers MSP Recovery (NASDAQ:MSPR) stock increased by 36.4% to $0.3 during Fri...
2025-11-01 05:07
Vyome Holdings Acquires AI Startup Oculo, Inc.
Vyome Holdings ( ($HIND) ) has provided an announcement. On September 29, 2025,...
2025-10-04 04:57
Vyome Acquires Oculo, An AI Startup Launched At The Massachusetts Institute Of Technology And Launched A New Business Unit Focused On Using AI To Tackle Inflammation; Deal Terms Were Undisclosed
This new business unit will leverage Oculo's assets to develop an AI psychiatrist trained on data from both the US and India, and will be overseen by a newly-formed Vyome Board of Directors AI subcommittee comprised of
2025-09-29 19:07
Vyome Stock (HIND) Rockets on Uveitis Study Data
Vyome stock rocketed higher on Wednesday after the company announced results of...
2025-09-17 20:54
Market-Moving News for September 17th
SPRC: 268% | SciSparc shares are trading higher after Automax Motors filed a motion to Jerusalem District Court in connection with its merger with the company. HIND: 199% | Vyome Unveils Preclinical Data
2025-09-17 19:20
Vyome Unveils Preclinical Data For VT-1908 Eye Drops To Treat Uveitis, A Leading Cause Of Blindness
Vyome Holdings, Inc. (NASDAQ:HIND), a clinical-stage healthcare holding company, presented results from its preclinical studies investigating VT-1908 (the first topical formulation of mycophenolate) for treating uveitis
2025-09-17 19:15
